Key clinical point: The guideline from the American Academy of Dermatology and the National Psoriasis Foundation focuses on the management, treatment, and care of pediatric psoriasis patients.
Major finding: Recommendations include using not only body surface area but also the Children’s Dermatology Life Quality Index to assess disease severity.
Study details: A multidisciplinary work group identified screening tools to measure disease severity, strategies for management of comorbidities, and the safety and effectiveness of topical, systemic, and phototherapy treatments for managing pediatric psoriasis.
Disclosures: Many of the guideline authors disclosed relationships with multiple companies; however, a minimum 51% of work group members had no relevant conflicts of interest in accordance with AAD policy. There was no funding source.
Menter A et al. J Am Acad Dermatol. 2019..